Role of c-KIT expression level and phosphatidylinositol 3-kinase activation in survival and proliferative responses of early myeloid cells

dc.contributor.authorYoung, Sonia M.en
dc.contributor.authorCambareri, Antony C.en
dc.contributor.authorAshman, Leonie K.en
dc.date.accessioned2025-12-31T18:41:52Z
dc.date.available2025-12-31T18:41:52Z
dc.date.issued2006en
dc.description.abstractThe receptor tyrosine kinase c-KIT and its ligand Stem Cell Factor (SCF) are critical in haemopoiesis but pathways linking receptor activation to specific responses in progenitor cells are still unclear. We have investigated the role of c-KIT expression level and the phosphatidylinositol 3-kinase (PI3-K) pathway in survival and cell division of early myeloid cells in response to SCF. Two factor-dependent murine early myeloid cell lines, FDC-P1 and Myb-immortalised haemopoietic cells (MIHC), were transduced to express wild-type c-KIT or a mutant form of the receptor (Y721F) that lacks the major recruitment site for the p85 regulatory subunit of PI3-K. Several clones expressing different receptor levels were analysed in each case. Growth of cells expressing either the wild-type or Y721F mutant KIT was strongly dependent on receptor level within the physiological range. Using an assay that allows quantitative measurement of the contributions of cell survival and cell division, diminished cell growth in response to SCF under limiting conditions of receptor copy number or PI3-K recruitment was shown to be almost entirely due to decreased cell survival. Further studies with the PI3-K inhibitor LY294002 indicated that PI3-K activation was also required for cell division. Alternate binding and/or indirect activation of PI3-K could support cell division mediated by Y721F mutant KIT, but was insufficient for the survival response.en
dc.description.sponsorshipWe thank Professor Christina Mitchell, Department of Biochemistry, Monash University for advice on the PI3-K assay, Dr Petranel Ferrao for providing MIHC and advice on retrovirus-mediated gene transfer, and Shoo-Peng Siah for technical assistance in the experiments shown in Fig. 7 B. This work was supported by a grant from the National Health and Medical Research Council of Australia of which LKA is a Principal Research Fellow. Professor Ashman's laboratory receives infrastructure funding from NSW Health through HMRI.en
dc.description.statusPeer-revieweden
dc.format.extent13en
dc.identifier.issn0898-6568en
dc.identifier.otherPubMed:16002264en
dc.identifier.scopus30944448636en
dc.identifier.urihttps://hdl.handle.net/1885/733797839
dc.language.isoenen
dc.sourceCellular Signallingen
dc.subjectc-KITen
dc.subjectHaemopoietic progenitor cellsen
dc.subjectPhosphatidylinositol 3-kinaseen
dc.subjectPI3-K inhibitorsen
dc.subjectSignal transductionen
dc.subjectY721F mutanten
dc.titleRole of c-KIT expression level and phosphatidylinositol 3-kinase activation in survival and proliferative responses of early myeloid cellsen
dc.typeJournal articleen
dspace.entity.typePublicationen
local.bibliographicCitation.lastpage620en
local.bibliographicCitation.startpage608en
local.contributor.affiliationYoung, Sonia M.; University of Newcastleen
local.contributor.affiliationCambareri, Antony C.; Institute of Medical and Veterinary Science Australiaen
local.contributor.affiliationAshman, Leonie K.; University of Newcastleen
local.identifier.citationvolume18en
local.identifier.doi10.1016/j.cellsig.2005.06.005en
local.identifier.puree9540c5a-cc0d-4fbd-b8bd-2bb50ded9342en
local.identifier.urlhttps://www.scopus.com/pages/publications/30944448636en
local.type.statusPublisheden

Downloads